Goiter, or thyroid enlargement, is common in people with Graves disease and can occur with other causes of hyperthyroidism as well
Imagine Drucker submitting a grant proposal today titled "Investigating Gila Monster Venom Proteins for Potential Therapeutic Applications." How would reviewers respond to: Unclear commercial potential No obvious connection to existing treatment paradigms High risk of "failure" (most venom studies don't yield drugs) Difficult to measure short-term impact Traditional funding metrics, publication counts, citation indices, immediate clinical relevance, would likely work against such proposals
If no benefits are evident after a few days, it is prudent to stop and reassess
Well, youve probably come across one ingredient being mentioned over and over again: glutathione
Follow @the.bazaar5 and @mykitchensnaps on Instagram
They found, as expected, that higher doses were associated with greater weight loss